Parallel Advisors’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.2K Buy
3,788
+259
+7% +$4.08K ﹤0.01% 1942
2026
Q1
$50.6K Buy
3,529
+235
+7% +$3.9K ﹤0.01% 1991
2025
Q4
$58.1K Hold
3,294
﹤0.01% 1768
2025
Q3
$51.8K Sell
3,294
-46
-1% -$646 ﹤0.01% 1772
2025
Q2
$37.1K Buy
3,340
+1,849
+124% +$21.7K ﹤0.01% 1892
2025
Q1
$17.4K Sell
1,491
-97
-6% -$1.25K ﹤0.01% 2208
2024
Q4
$21.7K Sell
1,588
-950
-37% -$13.8K ﹤0.01% 2111
2024
Q3
$42.4K Buy
2,538
+1,168
+85% +$17.1K ﹤0.01% 1720
2024
Q2
$16.3K Buy
1,370
+230
+20% +$2.63K ﹤0.01% 2095
2024
Q1
$13.7K Sell
1,140
-26
-2% -$387 ﹤0.01% 2167
2023
Q4
$19.6K Hold
1,166
﹤0.01% 1959
2023
Q3
$17.5K Hold
1,166
﹤0.01% 1914
2023
Q2
$22K Sell
1,166
-99
-8% -$1.57K ﹤0.01% 1804
2023
Q1
$22.7K Buy
1,265
+227
+22% +$3.79K ﹤0.01% 1771
2022
Q4
$8.65K Buy
+1,038
New +$7.75K ﹤0.01% 2087
2022
Q3
Sell
-26
Closed -$1K 3462
2022
Q2
$1K Buy
+26
New +$545 ﹤0.01% 2852
2022
Q1
Sell
-84
Closed -$2K 3245
2021
Q4
$2K Buy
+84
New +$2.01K ﹤0.01% 2757

Other funds holding SHC

Parallel Advisors's SHC Position: Q2 2026 in Review

Parallel Advisors increased its Sotera Health (SHC) stake by 7.3% in Q2 2026, buying an estimated $4.08K and bringing the position to 3,788 shares worth $67.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

Parallel Advisors first reported a position in SHC in Q4 2021 and has held it in 17 quarters since. 224 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Parallel Advisors held 3,788 shares of Sotera Health worth $67.2K as of Q2 2026.
  • Parallel Advisors bought 259 Sotera Health shares in Q2 2026, an estimated $4.08K.
  • Sotera Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1942 holding.
  • Parallel Advisors first reported a position in Sotera Health in Q4 2021 and has held it in 17 quarters since.
  • 224 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.